Clinical Trial Update: Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

View source ↗

Summary

Completed post-marketing surveillance study P04584 evaluated treatment with PegIntron Pen and Rebetol in HIV-infected patients with chronic hepatitis C. The res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• PegIntron Pen (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C, Hepatitis C | Status: COMPLETED | Results posted: 2013-04-08